Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - zoledronic acid as monohydrate - concentrate for solution for infusion - zoledronic acid as monohydrate 4 mg - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - lidocaine hydrochloride monohydrate - solution for injection - lidocaine hydrochloride monohydrate 10 mg / 1 ml - lidocaine - local and regional anaesthesia.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - lidocaine hydrochloride monohydrate - solution for injection - lidocaine hydrochloride monohydrate 20 mg / 1 ml - lidocaine - local and regional anaesthesia. severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be lifethreatening.

Israel - English - Ministry of Health

merck serono ltd - bisoprolol fumarate - tablets - bisoprolol fumarate 10 mg - bisoprolol - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension- coronary heart disease (angina pectoris)

Israel - English - Ministry of Health

merck serono ltd - bisoprolol fumarate - tablets - bisoprolol fumarate 5 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension- coronary heart disease (angina pectoris)

Israel - English - Ministry of Health

neopharm consumer products ltd, israel - polyethylene glycol 3350 - powder for oral solution - polyethylene glycol 3350 99.973 %w/w - macrogol - macrogol - treatment of constipation.

Israel - English - Ministry of Health

neopharm consumer products ltd, israel - polyethylene glycol 3350 - powder for oral solution - polyethylene glycol 3350 99.973 %w/w - macrogol - treatment of constipation.

Israel - English - Ministry of Health

neopharm consumer products ltd, israel - polyethylene glycol 3350 - powder for oral solution - polyethylene glycol 3350 99.365 %w/w - macrogol - treatment of constipation.

Israel - English - Ministry of Health

neopharm scientific ltd - a/california/7/2009 (h1n1)pdm09-like virus; a/hong kong/4801/2014 (h3n2) - like virus; b/brisbane/60/2008 - like virus - suspension for injection - b/brisbane/60/2008 - like virus 15 mcg / 0.5 ml; a/hong kong/4801/2014 (h3n2) - like virus 15 mcg / 0.5 ml; a/california/7/2009 (h1n1)pdm09-like virus 15 mcg / 0.5 ml - vaccinia immunoglobulin - vaccinia immunoglobulin - active immunisation against influenza in the elderly (65 years of age and over), especially for those with an infreased risk of associated complications (i.e. patients affected by underlying chronic diseases including diabetes, cardiovascular and respiratory diseases).

Israel - English - Ministry of Health

neopharm scientific ltd - cannabidiol drug substance ( cbd bds ); delta-9-tetrahydrocannabinol drug substance ( thc bds ) - oromucosal spray - cannabidiol drug substance ( cbd bds ) 25 mg / 1 ml; delta-9-tetrahydrocannabinol drug substance ( thc bds ) 27 mg / 1 ml - nabiximols - sativex is indicated, as add-on treatment, for symptom relief in patients with moderate to severe spasticity due to multiple sclerosis (ms) who have not responded adequately to other medication and who demonstrate at least 20 % improvement in spasticity related symptoms during a four week trial of therapy.